These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 39081499)
21. Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. Nittayananta W; Chanowanna N; Sripatanakul S; Winn T J Oral Pathol Med; 2001 Apr; 30(4):224-30. PubMed ID: 11302242 [TBL] [Abstract][Full Text] [Related]
22. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China]. Wen Y; Li C; Pei J; Bai J; Yang X; Duan K Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215 [TBL] [Abstract][Full Text] [Related]
23. Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India. Sharma G; Pai KM; Setty S; Ramapuram JT; Nagpal A Clin Oral Investig; 2009 Jun; 13(2):141-8. PubMed ID: 18668269 [TBL] [Abstract][Full Text] [Related]
24. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS. Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of oromucosal lesions in HIV positive patients receiving haart-A prospective clinical study. Maloth S; Shrinivas TR; Krishna Pramod B; Nagarathna PJ J Family Med Prim Care; 2020 Sep; 9(9):4821-4825. PubMed ID: 33209807 [TBL] [Abstract][Full Text] [Related]
26. Assessment of oral mucosal lesions among HIV positive transgenders residing in Odisha with and without Antiretroviral therapy. Rai S; Subramanyam GB; Kumar G; Bhushan V J Family Med Prim Care; 2022 Nov; 11(11):7106-7112. PubMed ID: 36993032 [TBL] [Abstract][Full Text] [Related]
27. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. Hamza OJ; Matee MI; Simon EN; Kikwilu E; Moshi MJ; Mugusi F; Mikx FH; Verweij PE; van der Ven AJ BMC Oral Health; 2006 Aug; 6():12. PubMed ID: 16916469 [TBL] [Abstract][Full Text] [Related]
28. Oral lesions in Brazilian HIV-infected children undergoing HAART. Miziara ID; Filho BC; Weber R Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081 [TBL] [Abstract][Full Text] [Related]
29. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503 [TBL] [Abstract][Full Text] [Related]
30. A real-world, cross sectional study of oral lesions and their association with CD4 cell counts and HIV viral load in Yunnan, China. Shu W; Li C; Du F; Bai J; Duan K Medicine (Baltimore); 2020 Oct; 99(40):e22416. PubMed ID: 33019418 [TBL] [Abstract][Full Text] [Related]
31. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients. Ortega KL; Vale DA; Magalhães MH J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845 [TBL] [Abstract][Full Text] [Related]
32. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Kerdpon D; Pongsiriwet S; Pangsomboon K; Iamaroon A; Kampoo K; Sretrirutchai S; Geater A; Robison V Oral Dis; 2004 May; 10(3):138-44. PubMed ID: 15089922 [TBL] [Abstract][Full Text] [Related]
33. Oral lesions associated with HIV/AIDS in HIV-seropositive patients attending a counselling and treatment centre in Dar es Salaam. Mwangosi IE; Tillya J Int Dent J; 2012 Aug; 62(4):197-202. PubMed ID: 23017001 [TBL] [Abstract][Full Text] [Related]
34. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial. Batavia AS; Secours R; Espinosa P; Jean Juste MA; Severe P; Pape JW; Fitzgerald DW PLoS One; 2016; 11(3):e0150656. PubMed ID: 26930571 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Oral Health-Related Quality of Life in Patient with Herpes-Associated Erythema Multiforme: A Unique Case Report. Bakti FU; Dewi TS Int Med Case Rep J; 2024; 17():253-259. PubMed ID: 38566932 [TBL] [Abstract][Full Text] [Related]
37. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. a nine year, cross-sectional, prospective study. Zakrzewska JM; Atkin PA Oral Health Prev Dent; 2003; 1(1):73-9. PubMed ID: 15643751 [TBL] [Abstract][Full Text] [Related]
38. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235 [TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin-E (IgE) Screening for Detecting Mouthwash Allergic Reactions with Recurrent Oral Erythema Multiforme: A Case Report. Pranadwista ZF; Hidayat W Int Med Case Rep J; 2024; 17():573-579. PubMed ID: 38854841 [TBL] [Abstract][Full Text] [Related]
40. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]